104 related articles for article (PubMed ID: 23328831)
1. Carbapenem-resistant Acinetobacter baumannii bacteremia in neonates.
Nakwan N; Chokephaibulkit K
Pediatr Infect Dis J; 2013 Feb; 32(2):197. PubMed ID: 23328831
[No Abstract] [Full Text] [Related]
2. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
Lee YT; Wang YC; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Yang YS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674056
[TBL] [Abstract][Full Text] [Related]
5. Tigecycline in carbapenem-resistant Acinetobacter baumannii bacteraemia: susceptibility and clinical outcome.
Kim NH; Hwang JH; Song KH; Choe PG; Kim ES; Park SW; Kim HB; Kim NJ; Park WB; Oh MD
Scand J Infect Dis; 2013 Apr; 45(4):315-9. PubMed ID: 23113680
[TBL] [Abstract][Full Text] [Related]
6. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia.
Yang YS; Wang YC; Kuo SC; Chen CT; Liu CP; Liu YM; Chen TL; Lee YT
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652230
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
[TBL] [Abstract][Full Text] [Related]
9. The impact of possible clonal spread of Acinetobacter baumannii complex bacteremia.
Hsu HY; Chao CM
Crit Care Med; 2014 Sep; 42(9):e628. PubMed ID: 25126810
[No Abstract] [Full Text] [Related]
10. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
[TBL] [Abstract][Full Text] [Related]
11. Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection.
Chuang L; Ratnayake L
Int J Antimicrob Agents; 2018 Oct; 52(4):521-522. PubMed ID: 30081140
[No Abstract] [Full Text] [Related]
12. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea.
Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS
Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for carbapenem- and multidrug-resistant Acinetobacter baumannii bacteremia in hematopoietic stem cell transplantation recipients.
Kim SB; Min YH; Cheong JW; Kim JS; Kim SJ; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2014 Feb; 46(2):81-8. PubMed ID: 24325335
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
Huang YS; Wang JT; Sheng WH; Chuang YC; Chang SC
J Microbiol Immunol Infect; 2015 Oct; 48(5):545-51. PubMed ID: 24662017
[TBL] [Abstract][Full Text] [Related]
17. Acinetobacter baumannii bacteraemia in Hong Kong.
You JH; Chow TC; Yeung AW; Lee N; Ip M
J Hosp Infect; 2010 May; 75(1):81. PubMed ID: 20299130
[No Abstract] [Full Text] [Related]
18. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei.
Tojo M; Mawatari M; Hayakawa K; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Takeshita N; Kutsuna S; Fujiya Y; Miyoshi-Akiyama T; Kirikae T; Ohmagari N
J Infect Chemother; 2015 Mar; 21(3):212-4. PubMed ID: 25444675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]